149 related articles for article (PubMed ID: 24264464)
1. Radiation therapy with concurrent retrograde superselective intra-arterial chemotherapy for gingival carcinoma.
Mukai Y; Hata M; Mitsudo K; Koike I; Koizumi T; Oguri S; Kioi M; Omura M; Tohnai I; Inoue T
Strahlenther Onkol; 2014 Feb; 190(2):181-5. PubMed ID: 24264464
[TBL] [Abstract][Full Text] [Related]
2. Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for stage III and IV oral cancer: analysis of therapeutic results in 112 cases.
Mitsudo K; Koizumi T; Iida M; Iwai T; Nakashima H; Oguri S; Kioi M; Hirota M; Koike I; Hata M; Tohnai I
Radiother Oncol; 2014 May; 111(2):306-10. PubMed ID: 24746571
[TBL] [Abstract][Full Text] [Related]
3. Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer.
Mitsudo K; Shigetomi T; Fujimoto Y; Nishiguchi H; Yamamoto N; Furue H; Ueda M; Itoh Y; Fuwa N; Tohnai I
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1428-35. PubMed ID: 20605340
[TBL] [Abstract][Full Text] [Related]
4. Thermochemoradiation therapy using superselective intra-arterial infusion via superficial temporal and occipital arteries for oral cancer with N3 cervical lymph node metastases.
Mitsudo K; Koizumi T; Iida M; Iwai T; Oguri S; Yamamoto N; Itoh Y; Kioi M; Hirota M; Tohnai I
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e639-45. PubMed ID: 22543212
[TBL] [Abstract][Full Text] [Related]
5. Laryngeal preservation in advanced piriform sinus squamous cell carcinomas using superselective intra-arterial chemoradiation therapy with three agents.
Furusaka T; Matsuda A; Tanaka A; Matsuda H; Ikeda M
Acta Otolaryngol; 2013 Mar; 133(3):318-26. PubMed ID: 23153059
[TBL] [Abstract][Full Text] [Related]
6. Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for T2-4N0 tongue cancer: control of occult neck metastasis.
Minamiyama S; Mitsudo K; Hayashi Y; Iida M; Iwai T; Nakashima H; Oguri S; Ozawa T; Koizumi T; Hirota M; Kioi M; Tohnai I
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Jul; 124(1):16-23. PubMed ID: 28434836
[TBL] [Abstract][Full Text] [Related]
7. Combined intra-arterial infusion and systemic chemoradiotherapy for stage IV squamous cell carcinoma of the mandibular gingiva.
Nakasato T; Izumisawa M; Akahane A; Kikuchi K; Ehara S; Shoji S; Kogi S; Mizuki H; Sugiyama Y
Jpn J Radiol; 2012 Nov; 30(9):752-61. PubMed ID: 22936237
[TBL] [Abstract][Full Text] [Related]
8. Phase 2 study of docetaxel, cisplatin, and concurrent radiation for technically resectable stage III-IV squamous cell carcinoma of the head and neck.
Inohara H; Takenaka Y; Yoshii T; Nakahara S; Yamamoto Y; Tomiyama Y; Seo Y; Isohashi F; Suzuki O; Yoshioka Y; Sumida I; Ogawa K
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):934-41. PubMed ID: 25832686
[TBL] [Abstract][Full Text] [Related]
9. Treatment results of alternating chemoradiotherapy followed by proton beam therapy boost combined with intra-arterial infusion chemotherapy for stage III-IVB tongue cancer.
Takayama K; Nakamura T; Takada A; Makita C; Suzuki M; Azami Y; Kato T; Hayashi Y; Ono T; Toyomasu Y; Hareyama M; Kikuchi Y; Daimon T; Mitsudo K; Tohnai I; Fuwa N
J Cancer Res Clin Oncol; 2016 Mar; 142(3):659-67. PubMed ID: 26521257
[TBL] [Abstract][Full Text] [Related]
10. Chemoradiotherapy using retrograde superselective intra-arterial infusion for tongue cancer: Analysis of therapeutic results in 118 cases.
Mitsudo K; Hayashi Y; Minamiyama S; Ohashi N; Iida M; Iwai T; Oguri S; Koizumi T; Kioi M; Hirota M; Koike I; Hata M; Tohnai I
Oral Oncol; 2018 Apr; 79():71-77. PubMed ID: 29598953
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and treatment outcomes of advanced maxillary gingival squamous cell carcinoma treated by intra-arterial infusion chemotherapy concurrent with radiotherapy.
Hayashi Y; Osawa K; Nakakaji R; Minamiyama S; Ohashi N; Ohya T; Iida M; Iwai T; Ozawa T; Oguri S; Koizumi T; Hirota M; Kioi M; Hata M; Mitsudo K
Head Neck; 2019 Jun; 41(6):1777-1784. PubMed ID: 30694002
[TBL] [Abstract][Full Text] [Related]
12. Retrograde intra-arterial chemotherapy and daily concurrent proton beam therapy for recurrent oral cavity squamous cell carcinoma: Analysis of therapeutic results in 46 cases.
Hayashi Y; Nakamura T; Mitsudo K; Yamaguchi H; Ono T; Azami Y; Takayama K; Suzuki M; Hatayama Y; Tsukiyama I; Hareyama M; Kikuchi Y; Fuwa N; Tohnai I
Head Neck; 2016 Aug; 38(8):1145-51. PubMed ID: 27018982
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of multidrug superselective intra-arterial chemotherapy (docetaxel, cisplatin, and 5-fluorouracil) using the Seldinger technique for tongue cancer.
Furusaka T; Asakawa T; Tanaka A; Matsuda H; Ikeda M
Acta Otolaryngol; 2012 Oct; 132(10):1108-14. PubMed ID: 22998559
[TBL] [Abstract][Full Text] [Related]
14. [Superselective intra-arterial infusion therapy with docetaxel, cisplatin and 5-fluorouracil for head and neck cancer--for tongue cancer patients in comparison patients with other therapies].
Furusaka T
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1241-6. PubMed ID: 16969018
[TBL] [Abstract][Full Text] [Related]
15. Salvage operations for patients with persistent or recurrent cancer of the maxillary sinus after superselective intra-arterial infusion of cisplatin with concurrent radiotherapy.
Sakashita T; Homma A; Hatakeyama H; Kano S; Mizumachi T; Furusawa J; Yoshida D; Fujima N; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Suzuki F; Fukuda S
Br J Oral Maxillofac Surg; 2014 Apr; 52(4):323-8. PubMed ID: 24582012
[TBL] [Abstract][Full Text] [Related]
16. Superselective intra-arterial chemoradiotherapy with docetaxel-nedaplatin for advanced oral cancer.
Kobayashi W; Teh BG; Sakaki H; Sato H; Kimura H; Kakehata S; Nagahata M
Oral Oncol; 2010 Dec; 46(12):860-3. PubMed ID: 21050802
[TBL] [Abstract][Full Text] [Related]
17. Comparison of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by radiation vs concurrent chemoradiotherapy with TPF in patients with locally advanced squamous cell carcinoma of the head and neck.
Katori H; Tsukuda M
Clin Oncol (R Coll Radiol); 2005 May; 17(3):148-52. PubMed ID: 15900997
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of concurrent chemoradiotherapy with retrograde super selective intra-arterial infusion combined with cetuximab for synchronous multifocal oral squamous cell carcinomas.
Chen X; Kioi M; Hayashi Y; Koizumi T; Koike I; Yamanaka S; Hata M; Mitsudo K
Radiat Oncol; 2023 May; 18(1):90. PubMed ID: 37237293
[TBL] [Abstract][Full Text] [Related]
19. Definitive chemoradiation therapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer: a phase 2 trial (KDOG 0501-P2).
Higuchi K; Komori S; Tanabe S; Katada C; Azuma M; Ishiyama H; Sasaki T; Ishido K; Katada N; Hayakawa K; Koizumi W;
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):872-9. PubMed ID: 24867539
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction.
Choong NW; Mauer AM; Haraf DC; Ferguson MK; Sandler AB; Kesler KA; Fishkin PA; Ansari RH; Wade J; Krauss SA; Sciortino DF; Posner MC; Kocherginsky M; Hoffman PC; Szeto L; Vokes EE
Med Oncol; 2011 Dec; 28 Suppl 1():S152-61. PubMed ID: 20730572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
